DB21751InvestigationalProtein Based Therapies
Vezocolmitide is under investigation in clinical trial NCT06178679 (Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)).
- Also known as
- ST-100
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Vezocolmitide, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account